Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
Netherlands
NL-Amsterdam-AMC, Amsterdam NL-Groningen-UMCG, Groningen NL-Maastricht-MUMC, Maastricht NL-Nijmegen-RADBOUDUMC, Nijmegen NL-Rotterdam-ERASMUSMC, Rotterdam NL-Utrecht-UMCUTRECHT, Utrecht Age range
18 Years and older
Last updated September 2024